2 Small-Cap Stocks With Far More Upside Than Any “Magnificent Seven” Stock, According to Wall Street

view original post

In the U.S. alone, the company estimates that 8,000 people die from melanoma every year; Iovance treated over 100 patients in the second quarter. Clearly, there’s more room to grow — and because …